Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA, MDMB-4F-BUTINACA and their analogs

Synthetic cannabinoid receptor agonists (SCRAs) continue to make up a significant portion new psychoactive substances (NPS) detected and seized worldwide. Due to their often potent activation of central cannabinoid receptors in vivo, use of SCRAs can result in severe intoxication, in addition to oth...

Descripción completa

Detalles Bibliográficos
Autores principales: Sparkes, Eric, Boyd, Rochelle, Chen, Shuli, Markham, Jack W., Luo, Jia Lin, Foyzun, Tahira, Zaman, Humayra, Fletcher, Charlotte, Ellison, Ross, McGregor, Iain S., Santiago, Marina J., Lai, Felcia, Gerona, Roy R., Connor, Mark, Hibbs, David E., Cairns, Elizabeth A., Glass, Michelle, Ametovski, Adam, Banister, Samuel D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558907/
https://www.ncbi.nlm.nih.gov/pubmed/36245876
http://dx.doi.org/10.3389/fpsyt.2022.1010501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558907/
https://www.ncbi.nlm.nih.gov/pubmed/36245876
http://dx.doi.org/10.3389/fpsyt.2022.1010501

Ejemplares similares